Zimmer Biomet Holdings (ZBH) Revenue (2009 - 2026)

Zimmer Biomet Holdings has reported Revenue for 18 years, with the latest figure at $2.2 billion in Q2 2026.

• On a quarterly basis, Revenue rose 4.8% year-over-year to $2.2 billion in Q2 2026; TTM through Jun 2026 was $8.5 billion, a 8.62% increase from a year earlier, with the FY2025 full-year figure at $8.2 billion, up 7.2% from the prior year.
• Revenue was $2.2 billion for Q2 2026 at Zimmer Biomet Holdings, up from $2.1 billion in the prior quarter.
• The five-year high for Revenue was $2.2 billion in Q4 2025, with the low at $1.7 billion in Q1 2022.
• Average Revenue over 5 years is $1.9 billion, with a median of $1.9 billion recorded in 2024.
• The sharpest annual moves came in 2022 and 2025: Revenue declined 0.93% in 2022, then increased 10.9% in 2025.
• Over 5 years, Revenue stood at $1.8 billion in 2022, then grew by 6.3% to $1.9 billion in 2023, then gained by 4.28% to $2.0 billion in 2024, then gained by 10.9% to $2.2 billion in 2025, then retreated by 2.98% to $2.2 billion in 2026.
• The last three Revenue figures came in at $2.2 billion (Q2 2026), $2.1 billion (Q1 2026), and $2.2 billion (Q4 2025), per Business Quant data.